Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;18(6):360-363.

Approach to Treatment Failure in Inflammatory Bowel Disease

Alan C Moss  1
Affiliations

Approach to Treatment Failure in Inflammatory Bowel Disease

Alan C Moss. Gastroenterol Hepatol (N Y). 2022 Jun.
No abstract available

PubMed Disclaimer

References

    1. Boyle MP, Moss AC, O’Toole AM, Vaughn B, Cheifetz AS. C-reactive protein as a predictor of low trough infliximab concentrations in patients who lose response to infliximab. J Dig Dis. 2017;18(12):678–683. - PubMed
    1. Moore C, Corbett G, Moss AC. Systematic review and meta-analysis: serum infliximab levels during maintenance therapy and outcomes in inflammatory bowel disease. J Crohns Colitis. 2016;10(5):619–625. - PMC - PubMed
    1. Moss AC. Putting TDM knowledge into practice. Frontline Gastroenterol. 2019;10(4):327. - PMC - PubMed
    1. O’Toole A, Moss AC. Optimizing biologic agents in ulcerative colitis and Crohn’s disease. Curr Gastroenterol Rep. 2015;17(8):32. - PubMed
    1. Volk N, Siegel CA. Defining failure of medical therapy for inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(1):74–77. - PubMed

LinkOut - more resources